Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity.


Journal

International archives of allergy and immunology
ISSN: 1423-0097
Titre abrégé: Int Arch Allergy Immunol
Pays: Switzerland
ID NLM: 9211652

Informations de publication

Date de publication:
2023
Historique:
received: 05 07 2022
accepted: 04 08 2022
pubmed: 13 10 2022
medline: 6 1 2023
entrez: 12 10 2022
Statut: ppublish

Résumé

Local allergic rhinitis (LAR) is, to date, a debated and complex entity, still orphan of global consideration and a multicentric approach. LAR does not seem to find a proper positioning in the classic classifications and phenotypes of chronic rhinitis, and its pathophysiology relies specifically on the presence of local IgE. These patients in fact have a suggestive clinical history of allergic rhinitis in the presence of negative skin prick tests and serum IgE tests for the suspect allergen. Nasal allergen challenge, assessment of local IgE, basophil activation test (BAT), and nasal cytology are, at the moment, the most used tests in the diagnostic approach to the disease, despite their limitations. Considering that the correct interpretation of diagnostic tests and their clinical relevance is fundamental in the assessment of the right diagnosis and the subsequent therapy, we propose a new diagnostic approach that encompasses all of these methodologies and suggest that several pragmatic randomized control trials as well as prospective, multicentric studies directed at the long-term follow-up of LAR be carried out to further investigate this debated entity.

Identifiants

pubmed: 36223735
pii: 000526604
doi: 10.1159/000526604
doi:

Substances chimiques

Immunoglobulin E 37341-29-0
Allergens 0

Types de publication

Journal Article Review Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-20

Commentaires et corrections

Type : CommentOn
Type : CommentOn

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Giulio Melone (G)

IRCCS Humanitas Research Hospital, Milan, Italy.

Veronica Giorgis (V)

SS Allergologia, Ospedale di Chivasso, Chivasso, Italy.

Marina Di Pino (M)

Private Practice, Giarre, Italy.

Corrado Pelaia (C)

Respiratory Medicine Unit, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.

Emanuele Nappi (E)

IRCCS Humanitas Research Hospital, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Enrico Heffler (E)

IRCCS Humanitas Research Hospital, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Massimo Landi (M)

National Pediatric Health Care System, Torino, Italy.
Institute of Biomedical Research and Innovation, Palermo, Italy.

Matteo Gelardi (M)

Unit of Otolaryngology, University of Foggia, Foggia, Italy.

Giovanni Paoletti (G)

IRCCS Humanitas Research Hospital, Milan, Italy, giovanni.paoletti@hunimed.eu.
Department of Biomedical Sciences, Humanitas University, Milan, Italy, giovanni.paoletti@hunimed.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH